IFR's upcoming US IPOs, follow-ons + convertibles
Near term pipeline of notable IPOs, follow-ons and convertible
offerings, from IFR and other sources:
** Jul 11: Cactus WHD.N (US, oilfield svcs) – $356m FO.
10m shs (100% sec) vs $35.60 last sale @ launch. CITI, CS
** Jul 11: Spero Therapeutics SPRO.O (US, biotech) – $78m
FO. 4.5m shs (100% prim) vs $17.39 last sale @ launch. COWN,
STFL, CANT
** Jul 11: Assembly Biosciences ASMB.O (US, biotech) –
$119m FO. 3m shs (100% prim) vs $39.78 last sale @ launch. JEFF,
WB, MIZU
** Jul 11: Cytomx Therapeutics CTMX.O (US, biotech) –
$125m FO. Shs TBD (100% prim) vs $24.63 last sale @ launch. GS,
CITI, BARC
** Jul 11: Natera NTRA.O (US, medtech) – $75m FO. Shs TBD
(100% prim) vs $21.04 last sale @ launch. JPM, MS, COWN
** Jul 17: Crinetics Pharmaceuticals (US, biotech) – $85m
IPO. 5m shs (100% prim), range $15-$17. JPM, LEER, PJ. Nasdaq
"CRNX"
** Jul 18: AFG AFGL.N (US, E&P equipment) – $328m IPO.
18.2m shs (30% prim), range $15-$18. GS, CS, SIMM, BARC, EVER,
UBS, WF
** Jul 18: Allakos (US, biotech) – $102m IPO. 6m shs (100%
prim), range $15-$17. GS, JEFF. Nasdaq "ALLK"
** Jul 18: Constellation Pharmaceuticals CNST.O (US,
biotech) – $85m IPO. 5.34m shs (100% prim), range $14-$16. JPM,
JEFF, BMO
** Jul 18: Establishment Labs (British Virgin Islands,
medtech) – $53m IPO. 3.13m shs (100% prim), range $15-$17. JEFF,
COWN. Nasdaq "ESTA"
** Jul 18: Rubius Therapeutics (US, biotech) – $210m IPO.
9.53m shs (100% prim), range $20-$22. JPM, MS, JEFF, LEER.
Nasdaq "RUBY"
** Jul 18: Tilray TLRY.O (US/Canada, medical cannabis
cultivation) – $144m IPO. 9m shs (100% prim), range $14-$16.
COWN, ROTH, NORTH. Includes Canadian offering
** Jul 18: First Western Financial (US, bank) - $39m IPO.
1.85m shs (81% prim), range $19-$21. KBW, STEPH, SAND
** Jul 19: Replimune (US, biotech) – $107m IPO. 6.7m shs
(100% prim), range $14-$16. JPM, LEER, BMO. Nasdaq "REPL"
** Jul 24: Bloom Energy (US, fuel cells) – $270m IPO. 18m
shs (100% prim), range $13-$15. JPM, MS, CS, KEYB, BAML. NYSE
"BE"
((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 646-223-5017))